The goal is to reduce side effects, improve tolerance, and lower treatment costs while still getting the metabolic benefits
Those who shouldnt take GLP-1 agonists include people who: are pregnant, nursing, or planning to become pregnant have a history of thyroid cancer or pancreatitis are allergic or sensitive to any of the GLP-1 medications have multiple endocrine neoplasia (MEN) syndrome type 2 Weight loss medications are not recommended for people with past or active eating disorders
Monitor your body weight, blood sugar levels, and potential side effects like queasiness or dry mouth
Participation in a clinical trial is the only legitimate and safe route to accessing retatrutide at this stage
Semaglutide is a glucagon-like peptide 1 receptor agonist used to improve metabolic health and support weight loss as an adjunct to lifestyle changes
Ready to Begin Your Journey Take your next step toward feeling lighter, healthier, and more supported